Shanghai Junshi Biosciences Co., Ltd.

Shanghai, Shanghai, China junshipharma.com

Overview

Shanghai Junshi Biosciences Co., Ltd. is a leading Chinese biopharmaceutical company focused on the discovery and development of innovative therapies. The company is committed to improving patient health by providing high-quality, affordable pharmaceuticals.

Therapeutic areas

OncologyImmunologyInfectious DiseasesMetabolic Diseases

API / Drug Master Files

Shanghai Junshi Biosciences Co., Ltd. holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • CARPTRANS TRANSFECTION REAGENT (GMP GRADE)Active2025-03-06
  • OPM-CHO CD07 DPMActive2024-06-05
  • OPM-293 CD05 MEDIUMActive2022-11-22

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Shanghai Junshi Biosciences Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Wuxi Biologics (Cayman) Inc.
China
Beigene, Ltd.
China
Guangzhou Gloria Biosciences Co., Ltd.
China
Innovent Biologics (Suzhou) Co., Ltd.
China
Leads Biolabs Co., Ltd.
China
Shanghai Bovax Biotechnology Co., Ltd.
China
Undefined Pharmaceuticals
China
Zhejiang Hisun Pharmaceutical Co., Ltd.
China

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo